Southland Equity Partners’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
Other funds holding CL
SP
PAM
CIM
AAMU
JIC
WG
Southland Equity Partners's CL Position: Q2 2026 in Review
Southland Equity Partners increased its Colgate-Palmolive (CL) stake by 0.36% in Q2 2026, buying an estimated $1.23K and bringing the position to 3,859 shares worth $354K. The position accounts for 0.06% of the portfolio, ranked #222.
Southland Equity Partners first reported a position in CL in Q4 2023 and has held it in 11 quarters since. The position peaked at $364K in Q1 2025. 658 funds tracked by Wall St. Rank hold CL as of Q2 2026.
- Southland Equity Partners held 3,859 shares of Colgate-Palmolive worth $354K as of Q2 2026.
- Southland Equity Partners bought 14 Colgate-Palmolive shares in Q2 2026, an estimated $1.23K.
- Colgate-Palmolive made up 0.06% of Southland Equity Partners's portfolio in Q2 2026, its #222 holding.
- Southland Equity Partners first reported a position in Colgate-Palmolive in Q4 2023 and has held it in 11 quarters since.
- Southland Equity Partners's Colgate-Palmolive position peaked at $364K in Q1 2025.
- 658 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.
Based on Southland Equity Partners's 13F filing for Q2 2026, filed 13 Jul 2026.